These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27955934)

  • 1. Quality of life in adults with facial port-wine stains.
    Hagen SL; Grey KR; Korta DZ; Kelly KM
    J Am Acad Dermatol; 2017 Apr; 76(4):695-702. PubMed ID: 27955934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial adjustment of children and adults with port wine stains.
    van der Horst CM; de Borgie CA; Knopper JL; Bossuyt PM
    Br J Plast Surg; 1997 Sep; 50(6):463-7. PubMed ID: 9326151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of quality of life and influencing factors in 197 Chinese patients with port-wine stains.
    Wang J; Zhu YY; Wang ZY; Yao XH; Zhang LF; Lv H; Zhang SP; Hu B
    Medicine (Baltimore); 2017 Dec; 96(51):e9446. PubMed ID: 29390578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-stigma and psychosocial burden of patients with port-wine stain: A systematic review and meta-analysis.
    Wanitphakdeedecha R; Sudhipongpracha T; Ng JNC; Yan C; Jantarakolica T
    J Cosmet Dermatol; 2021 Jul; 20(7):2203-2210. PubMed ID: 33949094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial stress of patients with port wine stains and expectations of dye laser treatment.
    Augustin M; Zschocke I; Wiek K; Peschen M; Vanscheidt W
    Dermatology; 1998; 197(4):353-60. PubMed ID: 9873174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.
    Dutkiewicz AS; Ezzedine K; Mazereeuw-Hautier J; Lacour JP; Barbarot S; Vabres P; Miquel J; Balguerie X; Martin L; Boralevi F; Bessou P; Chateil JF; Léauté-Labrèze C;
    J Am Acad Dermatol; 2015 Mar; 72(3):473-80. PubMed ID: 25592619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anatomic distribution of isolated and syndrome-associated port-wine stain.
    Elias AJ; Hand JL; Tollefson MM; Davis DMR
    Pediatr Dermatol; 2021 Jan; 38(1):77-82. PubMed ID: 33170527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial port-wine stains - clinical stratification and risks of neuro-ocular involvement.
    Ch'ng S; Tan ST
    J Plast Reconstr Aesthet Surg; 2008 Aug; 61(8):889-93. PubMed ID: 17604243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential psychological benefits from early treatment of port-wine stains in children.
    Troilius A; Wrangsjö B; Ljunggren B
    Br J Dermatol; 1998 Jul; 139(1):59-65. PubMed ID: 9764149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress and family satisfaction in parents of children with facial port-wine stains.
    Miller AC; Pit-Ten Cate IM; Watson HS; Geronemus RG
    Pediatr Dermatol; 1999; 16(3):190-7. PubMed ID: 10383773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with port-wine stains and their psychosocial reactions after photothermolytic treatment.
    Troilius A; Wrangsjö B; Ljunggren B
    Dermatol Surg; 2000 Mar; 26(3):190-6. PubMed ID: 10759791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains.
    Zallmann M; Mackay MT; Leventer RJ; Ditchfield M; Bekhor PS; Su JC
    Pediatr Dermatol; 2018 Sep; 35(5):575-581. PubMed ID: 30020536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split lesion randomized comparative study between long pulsed Nd:YAG laser 532 and 1,064 nm in treatment of facial port-wine stain.
    Al-Dhalimi MA; Al-Janabi MH
    Lasers Surg Med; 2016 Nov; 48(9):852-858. PubMed ID: 27669109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sturge-Weber syndrome in patients with facial port-wine stain.
    Piram M; Lorette G; Sirinelli D; Herbreteau D; Giraudeau B; Maruani A
    Pediatr Dermatol; 2012; 29(1):32-7. PubMed ID: 21906147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orodental manifestations of facial port-wine stains.
    Dowling MB; Zhao Y; Darrow DH
    J Am Acad Dermatol; 2012 Oct; 67(4):687-93. PubMed ID: 22226814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coping with illness and quality of life of patients with port-wine stains treated with laser therapy].
    Augustin M; Zschocke I; Wiek K; Bergmann A; Peschen M; Schöpf E; Vanscheidt W
    Hautarzt; 1998 Sep; 49(9):714-8. PubMed ID: 9794160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS).
    Passeron T; Salhi A; Mazer JM; Lavogiez C; Mazereeuw-Hautier J; Galliot C; Collet-Villette AM; Labreze C; Boon L; Hardy JP; Fayard V; Livideanu CB; Toubel G; Georgescou G; Gral N; Maza A; Lacour JP
    J Am Acad Dermatol; 2016 Jul; 75(1):64-8. PubMed ID: 27004804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Own clinical experience in treatment of port-wine stain with KTP 532 nm laser].
    Latkowski IT; Wysocki MS; Siewiera IP
    Wiad Lek; 2005; 58(7-8):391-6. PubMed ID: 16425790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathogenesis of Port Wine Stain and Sturge Weber Syndrome: Complex Interactions between Genetic Alterations and Aberrant MAPK and PI3K Activation.
    Nguyen V; Hochman M; Mihm MC; Nelson JS; Tan W
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophy in port-wine stains: prevalence and patient characteristics in a large patient cohort.
    van Drooge AM; Beek JF; van der Veen JP; van der Horst CM; Wolkerstorfer A
    J Am Acad Dermatol; 2012 Dec; 67(6):1214-9. PubMed ID: 22749320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.